SOX7 and Miyoshi myopathy: Based on the observations in other cancer types supporting the role of SOX7 as a tumor suppressor as well as a recent study showing SOX7 deletion in an MM case with double relapse [29], the genetic and/or epigenetic aberrations of SOX7 may be responsible for transcriptional downregulation of SOX7 in MM and allied neoplasms.